Evidence map›Paper›PMID 35743544›Full record

ArticleJournal of clinical medicine2022

Long-Term Outcome of Critically Ill Advanced Cancer Patients Managed in an Intermediate Care Unit.

Nerea Fernández Ros, Félix Alegre, Javier Rodríguez Rodriguez, Manuel F Landecho, Patricia Sunsundegui, Alfonso Gúrpide, Ramón Lecumberri, Eva Sanz, Nicolás García, Jorge Quiroga and 1 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nerea Fernández RosDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0001-6978-1659
Félix AlegreDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Javier Rodríguez RodriguezDepartment of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Manuel F LandechoDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-3234-8805
Patricia SunsundeguiDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Alfonso GúrpideDepartment of Oncology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Ramón LecumberriHematology Service, Clinica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-8850-8866
Eva SanzFaculty of Medicine, European University of Madrid, 28670 Madrid, Spain.
Nicolás GarcíaDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Jorge QuirogaDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Juan Felipe LucenaDepartment of Internal Medicine, Division of Intermediate Care and Hospitalists Unit, Clinica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0003-4999-6753

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To analyze the long-term outcomes for advanced cancer patients admitted to an intermediate care unit (ImCU), an analysis of a do not resuscitate orders (DNR) subgroup was made. Methods: A retrospective observational study was conducted from 2006 to January 2019 in a single academic medical center of cancer patients with stage IV disease who suffered acute severe complications. The Simplified Acute Physiology Score 3 (SAPS 3) was used as a prognostic and severity score. In-hospital mortality, 30-day mortality and survival after hospital discharge were calculated. Results: Two hundred and forty patients with stage IV cancer who attended at an ImCU were included. In total, 47.5% of the cohort had DNR orders. The two most frequent reasons for admission were sepsis (32.1%) and acute respiratory failure (excluding sepsis) (38.7%). Mortality in the ImCU was 10.8%. The mean predicted in-hospital mortality according to SAPS 3 was 51.9%. The observed in-hospital mortality was 37.5% (standard mortality ratio of 0.72). Patients discharged from hospital had a median survival of 81 (30.75−391.25) days (patients with DNR orders 46 days (19.5−92.25), patients without DNR orders 162 days (39.5−632)). The observed mortality was higher in patients with DNR orders: 52.6% vs. 23.8%, p 0 < 0.001. By multivariate logistic regression, a worse ECOG performance status (3−4 vs. 0−2), a higher SAPS 3 Score and DNR orders were associated with a higher in-hospital mortality. By multivariate analysis, non-invasive mechanical ventilation, higher bilirubin levels and DNR orders were significantly associated with 30-day mortality. Conclusion: For patients with advanced cancer disease, even those with DNR orders, who suffer from acute complications or require continuous monitoring, an ImCU-centered multidisciplinary management shows encouraging results in terms of observed-to-expected mortality ratios.

Indexed as

acute complicationsadvanced cancerdo not resuscitate ordershospitalistsintermediate care unit

Identifiers

PMID35743544
PMCPMC9225024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.